Evidence map›Paper›PMID 26042227›Full record

ArticleJournal of cancer biology & research2014

Cross-Phosphorylation and Interaction between Src/FAK and MAPKAP5/PRAK in Early Focal Adhesions Controls Cell Motility.

Sheila Figel Dwyer, Irwin H Gelman

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer biology & research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sheila Figel DwyerDepartment of Cancer Genetics, Roswell Park Cancer Institute, USA.
Irwin H GelmanDepartment of Cancer Genetics, Roswell Park Cancer Institute, USA.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12R01CA094108 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GELMAN, IRWIN H. · 2002 to 2014
$2.8M
Loss of FLJ13639 Expression in Acute LeukemiaR01CA116430 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SINGH, KESHAV K · 2006 to 2010
$1.4M
PKC/PKA in Prostate CancerR55CA094108 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GELMAN, IRWIN H. · 2002 to 2002
$100k
NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA094108NCI NIH HHS R01 CA116430NCI NIH HHS R55 CA094108
6 · The paper itself

Abstract

P38-regulated and activated kinase (PRAK/MAPKAPK5) is a serine/threonine kinase which lies downstream of the p38 and ERK3/4 MAP kinase pathways. PRAK plays diverse roles in the processes of cell growth, nutrient starvation response, programmed cell death, senescence and motility. PRAK has been shown to both promote and inhibit cell motility in different contexts. The pro-motility functions of PRAK are attributed mainly to cytoskeletal rearrangement occurring downstream of its phosphorylated substrate HSP27; however, it was recently shown that PRAK is required for motility in endothelial cells upstream of Focal adhesion kinase (FAK). Along with Src, FAK functions as a mediator of motility signaling through the phosphorylation of substrates in focal adhesions. Here, we show that PRAK, initially identified as a FAK substrate in an

Indexed as

FAKMAPKAPK5MK5RAKSrc

Identifiers

PMID26042227
PMCPMC4450445
OpenAlexW2405076250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.